Immunology
rhC1INH cuts attack frequency in hereditary angioedema
(HealthDay)—For patients with hereditary angioedema (HAE), weekly administration of recombinant C1INH (rhC1INH) is well tolerated and is associated with a reduction in attack frequency, according to a study published online ...
Nov 9, 2012
0
0